Food, Drugs, Healthcare, Life Sciences

With a focus on increasing business investment and growing industries of the future, the UK's Industrial Strategy released this week sets out its approach to driving long-term growth. Life sciences is identified...

Navigating the complexities of maintaining a stable supply chain in an ever-changing global environment is a key focus for FDA-regulated companies

As science evolves, policies may evolve as well. But when policy changes affect how a decision-maker exercises their discretion, those decision-makers must explain why they are taking a new approach.

On June 8, 2012, Genentech’s lawsuit seeking a declaration that US Patent No. 6,733,752 was invalid and not-infringed by Genentech’s trastuzumab product (HERCEPTIN).

Health Canada specifically contemplates certain proteins as SEBs in its Guidance, although Health Canada has not limited SEBs to only particular classes of drugs.

On May 23, 2012, the Federal Court held that Merck Frosst Canada Ltd. ("Merck") is liable to Apotex Inc. ("Apotex") for damages under section 8 of the Patented Medicines (Notice of Compliance) Regulations (the "Regulations"), but exercised its discretion to reduce the amount of compensation payable based on a defence of ex turpi causa.

With a focus on increasing business investment and growing industries of the future, the UK's Industrial Strategy released this week sets out its approach to driving long-term growth. Life sciences is identified...

The new Product Liability Directive marks the most significant overhaul of product liability law in nearly four decades.

The most recent and stringent legislative effort to restrict private equity investment in medical practices became law on June 9, 2025, when Oregon Gov. Tina Kotek signed Senate Bill 951 (SB 951).

With a focus on increasing business investment and growing industries of the future, the UK's Industrial Strategy released this week sets out its approach to driving long-term growth. Life sciences is identified...

On June 20, 2025, Texas Governor Greg Abbott signed into law Senate Bill 1318 (SB 1318), enacting sweeping new restrictions on non-compete agreements applicable to physicians...

As science evolves, policies may evolve as well. But when policy changes affect how a decision-maker exercises their discretion, those decision-makers must explain why they are taking a new approach.